Belluscura PLC (GB:BELL) has released an update.
Belluscura PLC, a UK-based medical device company specializing in portable oxygen enrichment technology, has granted 4 million share options to CFO Simon Neicheril. These options, recommended by the Remuneration Committee, have a 10-year term and an exercise price of 14.5 pence each, tied to the company’s share performance. They will vest when stock prices hit 20p and 25p, with immediate vesting upon certain company control changes or Neicheril’s employment termination as a ‘good leaver.’
For further insights into GB:BELL stock, check out TipRanks’ Stock Analysis page.
